Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2008-03-07
- Lead Sponsor
- Mylan Bertek Pharmaceuticals
- Target Recruit Count
- 630
- Registration Number
- NCT00145210
- Locations
- 🇺🇸
Mylan Pharmaceuticals Inc., Morgantown, West Virginia, United States
Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2005-09-02
- Lead Sponsor
- Mylan Bertek Pharmaceuticals
- Target Recruit Count
- 800
- Registration Number
- NCT00142545
- Locations
- 🇺🇸
Mylan Pharmaceuticals, Morgantown, West Virginia, United States
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Mylan Bertek Pharmaceuticals
- Target Recruit Count
- 336
- Registration Number
- NCT00142584
- Locations
- 🇺🇸
Mylan Pharmaceuticals Inc., Morgantown, West Virginia, United States
© Copyright 2024. All Rights Reserved by MedPath